07:44 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday the China State Administration for Market Regulation has approved the sale of its subsidiary in China to AstraZeneca ( AZN ) unit AstraZeneca Treasury.

FibroGen ( FGEN ) said the transaction remains on track to close in Q3, pending other contractual conditions and deliverables.

FibroGen ( FGEN ) said in February that it agreed to sell FibroGen China to AstraZeneca ( AZN ) for about $160 million.